As mentioned earlier, this time the finished product satisfies the transfusion standards required for humans. The first clinical test on humans will be carried out in late 2016 or early 2017. This research will also facilitate the production of blood on a larger scale which will eventually help hospitals in coping up with the blood shortage. The only reservation is the fact that this process must be insanely efficient and speedy since only in US, transfusions involve 14 million units of blood and one unit of blood contains a trillion of red blood cells.